Immune reconstitution from peripheral blood mononuclear cells inhibits lung carcinoma growth in NOD/SCID mice

Xiang Liu; Huiling Li; Jun Liu; Yubao Guan; Liyan Huang; Hailing Tang; Jianxing He

doi:10.3892/ol.2014.2379

Immune reconstitution from peripheral blood mononuclear cells inhibits lung carcinoma growth in NOD/SCID mice

Oncol Lett. 2014 Oct;8(4):1638-1644. doi: 10.3892/ol.2014.2379. Epub 2014 Jul 24.

Authors

Xiang Liu¹, Huiling Li², Jun Liu³, Yubao Guan⁴, Liyan Huang³, Hailing Tang³, Jianxing He³

Affiliations

¹ Department of Cardiothoracic Surgery, The Second Hospital Affiliated to University of South China, Hengyang, Hunan 421001, P.R. China ; Department of Cardiothoracic Surgery, Guangzhou Institute of Respiratory Disease, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical College, Guangzhou, Guangdong 510120, P.R. China.
² Department of Cardiothoracic Surgery, Guangzhou Institute of Respiratory Disease, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical College, Guangzhou, Guangdong 510120, P.R. China ; Department of Respiratory Medicine, Hainan Branch of Chinese PLA General Hospital, Sanya, Hainan 572000, P.R. China.
³ Department of Cardiothoracic Surgery, Guangzhou Institute of Respiratory Disease, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical College, Guangzhou, Guangdong 510120, P.R. China.
⁴ Department of Radiology, Guangzhou Institute of Respiratory Disease, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical College, Guangzhou, Guangdong 510120, P.R. China.

Abstract

Drug resistance and immune deficiency are important factors for the poor prognosis of lung carcinoma. The present study explored the possible protective effect of immune reconstitution from peripheral blood mononuclear cells (PBMCs) on multi-drug-resistant human lung carcinoma Am1010 cells in non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice. The inoculated tumor fragments grew rapidly in the NOD/SCID mice. The growth was significantly inhibited by intraperitoneal injection of PBMCs. In the mice injected with PBMCs, numerous CD3⁺ and CD8⁺ cells, but less CD4⁺ cells, were found in spleen and tumor tissues. These data suggest that PBMC transplantation inhibits lung carcinoma progression via the reconstitution of the immune system, particularly of cytotoxic T lymphocytes.

Keywords: Am1010; NOD/SCID; T lymphocytes; lung carcinoma; peripheral blood mononuclear cells.